SPONSORED FEATURE: INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER
IASLC has published books, posters, data sheets and new multidisciplinary classification of pulmonary
webinars to inform the lung cancer community of changes adenocarcinoma7 and is currently in the process of making
in the staging and pathological classification in use around a multidisciplinary classification for non-adenocarcinomas.
5
the world(http://iaslc.org/) . Lung cancer treatment
strategies which are known to be currently effective could ‰ IASLC contribution to developing health care systems:
be implemented into developing health care systems if In the first instance IASLC would be in a position to provide
adequate training and facilities are provided. advice and input into lung cancer awareness campaigns and
tobacco control measures. IASLC has developed web-
‰ Lung cancer pathology: In order to harmonize the based CME tools which can improve the performance of
histopathological classification of lung tumours all over the clinicians giving smoking cessation advice to patients
world, IASLC joined the World Health Organization in (http://iaslc.org/). The second phase of assistance would be
developing the “WHO/IASLC International Classification in the areas of lung cancer screening and the differing
of Lung and Pleural Tumors”6, and in recognition of the treatment modalities for lung cancer patients.
rapid development in molecular pathology (especially for However the most powerful reduction in lung cancer
patients with pulmonary adenocarcinomas), and the need deaths will be reached by primary prevention and mainly
for a multidisciplinary approach for management of by smoking cessation as tobacco is the primary cause of
patients with lung cancer, IASLC recommended later a lung cancer worldwide. l
Members of the IASLC Prevention Screening & Early Detection Committee
Jong Ho Park Korea Korea Cancer Center Hospital
John K Field United Kingdom University of Liverpool Cancer Research Centre
Carolyn Dresler USA Center for Tobacco Products, FDA
Rex Yung USA Johns Hopkins Medical Institutions
Ignacio Wistuba USA MD Anderson Cancer Center
Steven Dubinett USA David Geffen School of Medicine at UCLA
Nir Peled Israel Thoracic Cancer Research and Detection Center, Sheba Medical Center
Celine Mascaux Belgium Princess Margaret Cancer Center, University of Toronto
Pierre Massion USA Vanderbilt University
Gerald Schmidt-Bindert Germany University Medical Center Mannheim, Heidelberg University
Thomas D’Amico USA Duke University Medical Center
York Miller USA Denver Veterans Affairs Medical Center
Michael Unger USA Fox Chase Cancer Center
Egbert Smit Netherlands Vrije Universiteit Medical Centre
Carolyn R Aldige USA Prevent Cancer Foundation
Denise Aberle USA UCLA
Anne Fraser New Zealand Auckland District Health Board
Matthijs Oudkerk Netherlands Centre for Medical Imaging
1.
Athey VL, Suckling RJ, Tod AM, Walters SJ, Rogers TK: Early diagnosis of lung cancer: Lung Cancer Computed Tomography Screening Workshop 2011 Report. J Thorac
evaluation of a community-based social marketing intervention. Thorax 2012, Oncol 2012, 7(1):10-19.
67(5):412-417. 5.
Goldstraw P: IASLC Staging Manual in Thoracic Oncology. 1st ed Florida, USA:
2.
Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R: Smoking, smoking cessation, and EditorialRx Press 2009.
lung cancer in the UK since 1950: combination of national statistics with two case- 6.
WHO-IASLC: Classification of Lung- and Pleural Tumors. Springer-Verlag, Berlin 1999.
control studies. Bmj 2000, 321(7257):323-329.
7.
Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, Beer DG,
3.
Aberle DR, Berg CD, Black WC, Church TR, Fagerstrom RM, Galen B, Gareen IF, Powell CA, Riely GJ, Van Schil PE et al: International association for the study of lung
Gatsonis C, Goldin J, Gohagan JK et al: The National Lung Screening Trial: overview cancer/american thoracic society/european respiratory society international
and study design. Radiology 2011, 258(1):243-253. multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011,
4.
Field JK, Smith RA, Aberle DR, Oudkerk M, Baldwin DR, Yankelevitz D, Pedersen JH, 6(2):244-285.
Swanson SJ, Travis WD, Wisbuba, II et al: International Association for the Study of
52 CANCER CONTROL 2013